Early stage anal margin cancer: towards evidence-based management.
AffiliationDivision of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom
MetadataShow full item record
AbstractAnal squamous cell carcinoma is an uncommon Human Papilloma Virus (HPV)-related malignancy, the incidence of which has increased two- to four-fold over the past three decades. Results from the first three phase III trials, performed in the 1990s (the largest being the ACT I trial in the UK), established concurrent mitomycin C (MMC), 5-fluorouracil chemotherapy and radiotherapy (CRT) as the main primary treatment. Three subsequent trials (including ACT II in the UK, performed between 1998 and 2008, demonstrated evidence of no benefit from the use of additional chemotherapy before or after CRT, or concurrent cisplatin. This article is protected by copyright. All rights reserved.
CitationRenehan AG, Muirhead R, Berkman L, McParland L, Sebag-Montefiore D, PLATO trial management group. Early stage anal margin cancer: towards evidence-based management. Colorectal Dis. 2019 Jan 27.
- Primary surgery with or without postoperative radiotherapy in early stage squamous cell carcinoma in the anal canal and anal margin.
- Authors: Leon O, Hagberg O, Johnsson A
- Issue date: 2018 Sep
- Carcinoma of the anal canal: small steps in treatment advances.
- Authors: Eng C
- Issue date: 2011 Sep
- Management of Stage I Squamous Cell Carcinoma of the Anal Canal.
- Authors: Chai CY, Tran Cao HS, Awad S, Massarweh NN
- Issue date: 2018 Mar 1
- [Squamous cell cancer of the anal canal].
- Authors: Khysh VI, Timofeev IuM, Rottenberg VI
- Issue date: 1983
- [A case of long-term survival in stage IV squamous cell carcinoma of the anal canal with multidisciplinary treatment].
- Authors: Ogawa S, Fujishiro H, Fujiwara A, Tsukano K, Kotani S, Yamanouchi S, Kusunoki R, Aimi M, Miyaoka Y, Kohge N, Onuma H
- Issue date: 2017